Kodiak Sciences: Peers

The FY2025 (Dec) proxy of Kodiak Sciences names 17 peer companies for pay. Among Kodiak Sciences and these peers, CEO pay was 8th highest of 10 and total shareholder return was the highest of 10.

8th highest of 10in Kodiak Sciences and its pay peers, FY2025 (Dec) by CEO pay:

$2.1M$35.9M

1st highest of 10in Kodiak Sciences and its pay peers, FY2025 (Dec) by total shareholder return:

$9$391

Pay peer group, FY2025 (Dec) proxy

Ocular Therapeutix
MeiraGTx Holdings
AbCellera Biologics
Nektar Therapeutics
Ocugen
Regenxbio
Annexon
Fate Therapeutics
4D Molecular Therapeutics
Allogene TherapeuticsNot disclosedNot disclosed
Coherus BioSciencesNot disclosedNot disclosed
EyePoint PharmaceuticalsNot disclosedNot disclosed
Heron TherapeuticsNot disclosedNot disclosed
Mersana TherapeuticsNot disclosedNot disclosed
Prelude TherapeuticsNot disclosedNot disclosed
RAPT TherapeuticsNot disclosedNot disclosed
Viridian TherapeuticsNot disclosedNot disclosed
17 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.